Overhaul, a trailblazer in in-transit supply chain risk management, recently secured a substantial $105 million in Series C equity funding. This funding round was led by Springcoast Partners, with ...

Overhaul, a supply chain risk management company, secured $105 million in Series C funding, led by Springcoast Partners, and a new debt facility. The funding will fuel platform innovation, AI ...

CINCINNATI — On Sunday, the Cincinnati Reds played a cleaner game than the Milwaukee Brewers and won, snapping the Brewers’ 14-game winning streak. The Brewers’ overall domination of the Reds ...

Watch the latest MLB The Show 25 trailer to see the announcement that David Wright, Andy Pettitte, Jorge Posada and more legends are available today (August 15, 2025) in the Signature Series Program.

BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience. Its wholly owned subsidiary, OnkosXcel ...

SCOTTSDALE, Ariz., Aug. 12, 2025 /PRNewswire/ -- Jocasta Neuroscience, Inc., a preclinical stage, longevity-focused company, with its lead asset, a proprietary formulation of the longevity protein, a ...

Mumbai-based healthtech startup Truemeds has closed its $85 Mn (around INR 740 Cr) Series C funding round from Accel, Peak XV Partners, WestBridge Capital and Info Edge Ventures. The fresh capital has ...

RALEIGH, N.C. (WNCT) — To help crack down on speeding, the North Carolina Governor’s Highway Safety Program and law enforcement agencies are launching the “Speeding Catches Up With You” campaign.

U.S. firm CertifID, which provides wire fraud protection and recovery for the real estate industry, has announced a $47.5 million Series C funding round led by Centana Growth Partners, to support ...

LEICESTER — One of the highlights of the weekend was the presence of Paul “Fast By” Gast, he served as Grand Marshall of the Pro Bike & Sled Series (PBSS) participates in the PBSS team meetings, along ...

FELIQS Corporation (“FELIQS”), a biotechnology company developing first-in-class small molecule therapeutics targeting oxidized lipids for rare pediatric retinal diseases, today announced the ...